SPACInsider Logo
The Latest SPAC News and Rumors: November 15, 2022
by Marlena Haddad on 2022-11-15 at 11:33am

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Elliott discloses new stake in Clarivate, Virusight and Technogenetics expand collaboration, and Apollomics receives FDA Orphan Drug Designation  


Elliott Takes Stake in Clarivate With Take-Private Wave Rising

Elliott Investment Management disclosed a new stake in Clarivate Plc (NYSE:CLVT) amid a wave of take-private transactions in the information services sector.

Clarivate is a provider of critical data, insights and analytics used by universities, corporations, the legal community and other institutions around the world, according to its website. It was purchased from Thomson Reuters Corp. in 2016 by a group of investors led by Onex Corp. and Baring Private Equity Asia.

The company went public in 2019 through a merger with a special purpose acquisition company led by Michael Klein. Several of its top investors are private equity companies, including Leonard Green & Partners, which is its largest shareholder with a 17.3% stake in the company, according to data compiled by Bloomberg.

READ

Virusight and Technogenetics to Expand Collaboration for Global Deployment of Innovative Spectral-Based Pathogens Diagnosis

Virusight Diagnostic (a joint venture subsidiary of Newsight Imaging Ltd.) and Technogenetics today signed a Memorandum of Understanding to expand their collaboration for worldwide commercialization of the 20-second COVID-19 diagnosis solution and to develop additional diagnostic applications utilizing the technology.

On August 30, 2022, Newsight Imaging announced that it has entered into a definitive agreement to become publicly listed through a merger transaction with Vision Sensing Acquisition Corp. (Nasdaq: VSAC), a publicly traded special purpose acquisition company.

READ

Apollomics Inc. Receives FDA Orphan Drug Destination for Vebreltinib for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations 

Apollomics, Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to vebreltinib (APL-101) for the treatment of non-small cell lung cancer (NSCLC) with MET genomic tumor aberrations. The FDA granted the Orphan Drug Designation in August.

As previously announced on Sept. 14, 2022, Apollomics and Maxpro Capital Acquisition Corp. (Nasdaq: JMAC, JMACU, JMACW), announced a definitive agreement for a business combination that would result in Apollomics becoming a publicly traded company on the Nasdaq Global Market.

READ

AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of AUM001 for Treatment of Metastatic Colorectal Cancer in Australia

AUM Biosciences Pte. Ltd. (“AUM”), a clinical-stage biotechnology company, advancing a clinical stage candidate and a broader pipeline designed to deploy multi-faceted inhibition strategies to reverse cancer resistance, today announced it has received Human Research Ethics Committee (“HREC”) approval to commence a Phase II clinical trial of its selective translation inhibitor AUM001 in Australia. Ethics approval is confirmation that AUM has completed all the necessary pre-clinical safety and efficacy testing of AUM001 required to commence its Phase II clinical trial in Australia.

Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

READ

 

Recent Posts
by Marlena Haddad on 2022-12-06 at 5:43pm

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC Liquidations: Broadscale, Revolution Healthcare, Research Alliance II, and Kairos Broadscale Acquisition Corp. to Liquidate  On December 6, 2022, stockholders of Broadscale Acquisition Corp. (NASDAQ:SCLE) approved amendments to change the termination date from February 17,...

by Nicholas Alan Clayton on 2022-12-06 at 1:02pm

Roth CH Acquisition IV Co. (NASDAQ:ROCG) has entered into a definitive agreement to combine with renewable energy equipment-maker Tigo for pre-money equity consideration of $600 million. Campbell, California-based Tigo manufacturers components that optimize and enhance safety for solar panel arrays, with installations on seven continents The combined company is expected to trade on the Nasdaq...

by Marlena Haddad on 2022-12-06 at 12:55am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Portugal real estate developer Vic Properties in merger talks with BurTech Caner-Led Aggregate Is Said to Discuss Vic Properties SPAC Deal Aggregate Holdings SA is in talks to take its Portuguese unit Vic...

by Marlena Haddad on 2022-12-06 at 11:11am

SportsMap Tech Acquisition Corp. (NASDAQ:SMAP) has entered into a definitive agreement to combine with intelligent thermal imaging provider Infrared Cameras Holdings (ICI) at a pre-money equity valuation of $100 million. Beaumont, Texas-based Infrared Cameras Holdings develops and manufactures infrared-sensor systems, offering handheld and fixed hardware. The combined company is expected to trade on the Nasdaq once the...

by Nicholas Alan Clayton on 2022-12-06 at 10:24am

Ares Acquisition Corporation (NYSE:AAC) has entered into a definitive agreement to combine with nuclear power company X-energy at an enterprise value of $2.2 billion. Rockville, Maryland-based X-energy has developed small modular nuclear reactor technology designed to provide nuclear plants for projects ranging from individual industrial sites to regional utilities. The combined company is expected to...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved